In our latest Liberty Update, we highlight an eye-opening new study confirming how drug price controls…
CFIF on Twitter CFIF on YouTube
AEI's Michael Rosen: "Omicron Variant Sows Chaos but Doesn’t Move Needle on Patent Waiver Debate"

In our latest Liberty Update, we highlight an eye-opening new study confirming how drug price controls kill pharmaceutical investment and innovation at the worst possible time, when America and the entire world depend upon them more than ever.

In similar vein, American Enterprise Institute (AEI) Adjunct Fellow and healthcare expert Michael Rosen nicely illustrates how the omicron variant of Covid has paused the destructive global effort to suspend enforcement of patent rights belonging to lifesaving vaccine developers:

But the new omicron variant of the virus has intervened, shelving the planned WTO meeting and throwing into continued contrast the supposed haves and have-nots of vaccine protection...  But the EU has held firm in resisting the vaccine waiver, and rightly so."

Unfortunately…[more]

December 06, 2021 • 12:20 PM

Liberty Update

CFIFs latest news, commentary and alerts delivered to your inbox.
Home Press Room CFIF Urges Withdrawal of "Most Favored Nation" Executive Order
CFIF Urges Withdrawal of "Most Favored Nation" Executive Order Print
Monday, November 16 2020

 November 16, 2020

The Honorable Donald J. Trump 
President of the United States 
The White House 
1600 Pennsylvania Avenue NW 
Washington, DC 20500

Dear President Trump,

On behalf of our more than 300,000 activists and supporters across the country, the Center for Individual Freedom (CFIF) urges you to halt implementation of and immediately withdraw the “most favored nation” (MFN) executive order that will impose foreign price controls on American medicines. 

The executive order relies on an International Pricing Index (IPI) to determine “most favored nation” pricing for Medicare Parts B and D drugs, meaning the price controls of foreign nations, many of which have socialized medicine systems, will control reimbursement rates here in the United States. 

More than 80 free-market and center-right organizations, led by Americans for Tax Reform and including CFIF, remain united in our strong opposition to the order. As that massive coalition wrote a few months ago, “Adopting these price controls will slow medical innovation, threaten American jobs, and undermine criticism of single-payer systems. In addition, a United States embrace of price controls will make it immeasurably more difficult to get foreign countries to pay their own way in the development of new medicines.”

Moreover, as CFIF pointed out in July when the Administration first announced its executive order, and again when the order was expanded and advanced in September, price controls simply do not work, regardless of the product targeted or the country in which they’re attempted, and real-world experience establishes that pharmaceutical price controls are no different.  

For example, other nations receive far fewer new lifesaving and life-improving drugs than American consumers, which enjoyed access to 96% of all new cancer drugs over the past decade. In contrast, only 56% of those same drugs became available in Canada, merely 50% became available in Japan and only 11% in Greece, as just three examples. The MFN order threatens that access.

Finally, the MFN executive order contradicts the preferences of U.S. consumers and voters regarding the general role of government in health care. A recent national survey conducted by Public Opinion Strategies for CFIFmeasured the health care priorities of voters nationally and in 12 key swing states ahead of the November 2020 election.  It found that “voters, across party, overwhelmingly prefer the role of the federal government to be that of providing oversight and incentives to health care providers, prescription drug companies and health insurers to encourage competition to lower prices in the health care system (70%) rather than having the federal government set prices and determine what services and medicines are covered by private health plans (30%).”   

For those reasons and others, we again strongly encourage you to halt implementation of the MFN executive order and withdraw it.

Thank you for your time and consideration on this important issue.

Sincerely, 
/s/
Jeffrey Mazzella
President 
 
Related Articles :
Quiz Question   
Which of the following is famously known as “a date which will live in infamy”?
More Questions
Notable Quote   
 
"As a member of Congress, Rep. Alexandria Ocasio-Cortez makes a whopping $174,000 annually, meaning that she individually earns more than twice the average U.S. household's income. Yet the progressive Democrat nonetheless thinks that working-class taxpayers should have to pay off her student loan debt.That's one of the main takeaways from Ocasio-Cortez's latest speech on the House floor. In the congresswoman…[more]
 
 
—Brad Polumbo, Freelance Writer
— Brad Polumbo, Freelance Writer
 
Liberty Poll   

In your Christmas shopping thus far, how are you faring?